BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 20627831)

  • 1. Familial pancreatic cancer in Italy. Risk assessment, screening programs and clinical approach: a position paper from the Italian Registry.
    Del Chiaro M; Zerbi A; Capurso G; Zamboni G; Maisonneuve P; Presciuttini S; Arcidiacono PG; Calculli L; Falconi M;
    Dig Liver Dis; 2010 Sep; 42(9):597-605. PubMed ID: 20627831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance.
    Canto MI; Almario JA; Schulick RD; Yeo CJ; Klein A; Blackford A; Shin EJ; Sanyal A; Yenokyan G; Lennon AM; Kamel IR; Fishman EK; Wolfgang C; Weiss M; Hruban RH; Goggins M
    Gastroenterology; 2018 Sep; 155(3):740-751.e2. PubMed ID: 29803839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PanGen-Fam: Spanish registry of hereditary pancreatic cancer.
    Mocci E; Guillen-Ponce C; Earl J; Marquez M; Solera J; Salazar-López MT; Calcedo-Arnáiz C; Vázquez-Sequeiros E; Montans J; Muñoz-Beltrán M; Vicente-Bártulos A; González-Gordaliza C; Sanjuanbenito A; Guerrero C; Mendía E; Lisa E; Lobo E; Martínez JC; Real FX; Malats N; Carrato A
    Eur J Cancer; 2015 Sep; 51(14):1911-7. PubMed ID: 26212471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress report: familial pancreatic cancer.
    Mintziras I; Bartsch DK
    Fam Cancer; 2019 Jul; 18(3):359-362. PubMed ID: 30796632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary vs Familial Pancreatic Cancer: Associated Genetic Syndromes and Clinical Perspective.
    Copur MS; Talmon GA; Wedel W; Hart JD; Merani S; Vargasi LM
    Oncology (Williston Park); 2020 Jun; 34(6):196-201. PubMed ID: 32609864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parameters.
    Urayama S
    World J Gastroenterol; 2015 Feb; 21(6):1707-17. PubMed ID: 25684935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Italian registry of families at risk of pancreatic cancer: AISP Familial Pancreatic Cancer Study Group.
    Capurso G; Paiella S; Carrara S; Butturini G; Secchettin E; Frulloni L; Zerbi A; Falconi M
    Dig Liver Dis; 2020 Oct; 52(10):1126-1130. PubMed ID: 32819857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical familial presentation of FAMMM syndrome with a high incidence of pancreatic cancer: case finding of asymptomatic individuals by EUS surveillance.
    Kluijt I; Cats A; Fockens P; Nio Y; Gouma DJ; Bruno MJ
    J Clin Gastroenterol; 2009 Oct; 43(9):853-7. PubMed ID: 19417680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of First-Round of Surveillance in Individuals at High-Risk of Pancreatic Cancer from the AISP (Italian Association for the Study of the Pancreas) Registry.
    Paiella S; Capurso G; Cavestro GM; Butturini G; Pezzilli R; Salvia R; Signoretti M; Crippa S; Carrara S; Frigerio I; Bassi C; Falconi M; Iannicelli E; Giardino A; Mannucci A; Laghi A; Laghi L; Frulloni L; Zerbi A
    Am J Gastroenterol; 2019 Apr; 114(4):665-670. PubMed ID: 30538291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening of Patients at Risk for Familial Pancreatic Cancer: What Is Beneficial?
    Torphy RJ; Schulick RD
    Surg Clin North Am; 2018 Feb; 98(1):25-35. PubMed ID: 29191275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic Cancer Surveillance and Novel Strategies for Screening.
    Dudley B; Brand RE
    Gastrointest Endosc Clin N Am; 2022 Jan; 32(1):13-25. PubMed ID: 34798981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening and Surveillance for Pancreatic Adenocarcinoma in High-Risk Individuals.
    Labiner AJ; Aronson A; Lucas AL
    Hematol Oncol Clin North Am; 2022 Oct; 36(5):929-942. PubMed ID: 36265991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications and issues related to familial pancreatic cancer: a cohort study of hospitalized patients.
    Mughetti M; Calculli L; Chiesa AM; Ciccarese F; Rrusho O; Pezzilli R
    BMC Gastroenterol; 2016 Jan; 16():6. PubMed ID: 26767414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No longer the new kid.
    Ahmad NA
    Gastrointest Endosc; 2009 Sep; 70(3):495-7. PubMed ID: 19699979
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of a high risk pancreatic screening clinic using 3.0 T MRI.
    Barnes CA; Krzywda E; Lahiff S; McDowell D; Christians KK; Knechtges P; Tolat P; Hohenwalter M; Dua K; Khan AH; Evans DB; Geurts J; Tsai S
    Fam Cancer; 2018 Jan; 17(1):101-111. PubMed ID: 29101607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial pancreatic cancer.
    Rieder H; Bartsch DK
    Fam Cancer; 2004; 3(1):69-74. PubMed ID: 15131409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Familial pancreatic cancer].
    Zalatnai A
    Magy Onkol; 2006; 50(2):163-8. PubMed ID: 16888680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer risk among the relatives of patients with pancreatic ductal adenocarcinoma.
    Del Chiaro M; Zerbi A; Falconi M; Bertacca L; Polese M; Sartori N; Boggi U; Casari G; Longoni BM; Salvia R; Caligo MA; Di Carlo V; Pederzoli P; Presciuttini S; Mosca F
    Pancreatology; 2007; 7(5-6):459-69. PubMed ID: 17912010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance for individuals at high-risk of pancreatic cancer: Are we finally heading toward evidence?
    Capurso G
    United European Gastroenterol J; 2019 Apr; 7(3):341-342. PubMed ID: 31019701
    [No Abstract]   [Full Text] [Related]  

  • 20. Imaging of pancreatic neoplasms.
    Balachandran A; Bhosale PR; Charnsangavej C; Tamm EP
    Surg Oncol Clin N Am; 2014 Oct; 23(4):751-88. PubMed ID: 25246049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.